✦ LIBER ✦

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

✍ Scribed by Kullmann, F; Hollerbach, S; Dollinger, M M; Harder, J; Fuchs, M; Messmann, H; Trojan, J; Gäbele, E; Hinke, A; Hollerbach, C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab plus gemcitabine and oxalipl

✍ David Fogelman; Mehrdad Jafari; Gauri R. Varadhachary; Henry Xiong; Susie Bulloc 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB

Multicentric phase II trial of gemcitabi

✍ Cappuzzo, F; Mazzoni, F; Gennari, A; Donati, S; Salvadori, B; Orlandini, C; Cett 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

Cetuximab plus oxaliplatin/leucovorin/5-

✍ Lordick, F; Luber, B; Lorenzen, S; Hegewisch-Becker, S; Folprecht, G; Wöll, E; D 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 269 KB

Gemcitabine and oxaliplatin combination

✍ Kyung Hee Lee; Min Kyoung Kim; Yeol Hong Kim; Baek Yeol Ryoo; Ho Yeong Lim; Hong 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 341 KB

A phase II study of bevacizumab plus erl

✍ Andrew H. Ko; Alan P. Venook; Emily K. Bergsland; R. Kate Kelley; W. Michael Kor 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 266 KB

Phase II study of gemcitabine plus oxali

✍ Cappuzzo, F; Novello, S; De Marinis, F; Franciosi, V; Maur, M; Ceribelli, A; Lor 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB